BlackRock Inc. - REGENCELL BIOSCIENCE HLDGS L ownership

REGENCELL BIOSCIENCE HLDGS L's ticker is and the CUSIP is G7487R100. A total of 6 filers reported holding REGENCELL BIOSCIENCE HLDGS L in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of REGENCELL BIOSCIENCE HLDGS L
ValueSharesWeighting
Q3 2023$3,332
-35.5%
2380.0%0.00%
Q2 2023$5,165
-16.1%
2380.0%0.00%
Q1 2023$6,159
-4.9%
2380.0%0.00%
Q4 2022$6,474
-19.1%
2380.0%0.00%
Q3 2022$8,0000.0%2380.0%0.00%
Q2 2022$8,0002380.00%
Other shareholders
REGENCELL BIOSCIENCE HLDGS L shareholders Q2 2022
NameSharesValueWeighting ↓
Qube Research & Technologies Ltd 17,329$371,0000.00%
UBS Group AG 244$5,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 2,240$48,0000.00%
MORGAN STANLEY 6$00.00%
Tower Research Capital LLC (TRC) 432$10,0000.00%
View complete list of REGENCELL BIOSCIENCE HLDGS L shareholders